~~UNITED STATES~~ SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report: August 30, 2005 (Date of earliest event reported)~~: May 18, 2005~~

SINOFRESH HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Florida	0-49764	65-1082270
(State or other jurisdiction	(Commission File Number)	(IRS Employer
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)
of incorporation)		Identification No.)
516 Paul Morris Drive, Englewood, Florida		34223
(Address of principal executive offices)		(Zip Code)

~~Registrant’s~~516 ~~telephone~~Paul Morris Drive ~~number~~Englewood, ~~including~~Florida ~~area~~34223 (Address ~~code:~~of ~~(941~~principal executive offices, zip code) ~~681-3100~~

(~~Former~~941) 681-3100 (Registrant’s ~~name~~telephone ~~or former address~~number, ifincluding ~~changed~~area ~~since last report.~~code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

oItem 5.02. ~~Soliciting~~Resignation ~~material~~of ~~pursuant~~Executive toVice ~~Rule 14a-12 under the Exchange Act (17 CFR 240~~President.~~14a-12)~~

o On ~~Pre-commencement~~August 26, ~~communications~~2005, ~~pursuant~~the Registrant received notice, from P. Robert DuPont of his intent to resign ~~Rule~~his ~~14d-2(b)~~position ~~under~~as Executive Vice President effective September 30, 2005. Mr. DuPont’s primary responsibilities were overseeing operations, business development and research and development. These responsibilities will now be divided among several existing employees of the ~~Exchange~~Company. ~~Act~~Mr. DuPont ~~(17~~will ~~CFR~~continue ~~240~~serving on the Company’s Board of Directors.~~14d-2(b))~~

oItem 9.01. ~~Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240~~Exhibits.~~13e-4(c))~~

Item 2.02. Results of Operations and Financial Condition.


Exhibit No.		Item
99.1		Notice of Resignation dated August 26, 2005.

~~On May 18, 2005, the Registrant issued the press release attached hereto as Exhibit 99.1.~~Signatures

~~Item~~ Pursuant ~~9.01.~~to ~~Exhibits~~the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit No.		Item
	SINOFRESH HEALTHCARE, INC.
99.1		Press Release dated May 18, 2005.
Date: August 30, 2005		/s/ Scott M. Klein
	Name:	Scott M. Klein
	Title:	Chief Financial Officer (Principle Accounting Officer)

~~Signatures~~- 2 -

Pursuant to the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SINOFRESH HEALTHCARE, INC.
Date: May 18, 2005	/s/ Scott M. Klein
	Name:	Scott M. Klein
	Title:	Chief Financial Officer (Principal Accounting Officer)

-2-

Filing Compare · SINOFRESH HEALTHCARE INC